| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.871 | 0.003 | 0.871 | Epidermal growth factor receptor kinase inhibitor | 0.473 0.005 CID_154700086 | ||
| 0.842 | 0.002 | 0.842 | ErbB-1 antagonist | 0.662 0.004 CID_154700086 | ||
| 0.79 | 0.003 | 0.79 | Epidermal growth factor antagonist | 0.352 0.006 CID_154700086 | ||
| 0.772 | 0.005 | 0.772 | Growth factor antagonist | 0.256 0.034 CID_154700086 | ||
| 0.699 | 0.008 | 0.699 | Aldehyde oxidase inhibitor | |||
| 0.665 | 0.004 | 0.665 | ErbB-2 antagonist | 0.241 0.007 CID_154700086 | ||
| 0.588 | 0.018 | 0.588 | Angiogenesis inhibitor | 0.585 0.018 CID_154700086 | ||
| 0.567 | 0.004 | 0.567 | MAP kinase kinase 2 inhibitor | |||
| 0.563 | 0.006 | 0.563 | Vascular endothelial growth factor antagonist | 0.112 0.074 CID_154700086 | ||
| 0.539 | 0.006 | 0.539 | Vascular endothelial growth factor 2 antagonist | 0.087 0.081 CID_154700086 | ||
| 0.512 | 0.005 | 0.512 | RET inhibitor | 0.129 0.072 CID_154700086 | ||
| 0.486 | 0.003 | 0.486 | MAP kinase kinase inhibitor | |||
| 0.463 | 0.005 | 0.463 | Ephrin antagonist | 0.234 0.017 CID_154700086 | ||
| 0.453 | 0.013 | 0.453 | Platelet aggregation inhibitor | 0.346 0.026 CID_154700086 | ||
| 0.432 | 0.005 | 0.432 | Platelet activating factor beta antagonist | 0.103 0.06 CID_154700086 | ||
| 0.428 | 0.004 | 0.428 | ErbB-4 antagonist | 0.156 0.019 CID_154700086 | ||
| 0.432 | 0.022 | 0.557 | DNA damaging | 0.557 0.01 CID_154700086 | CID_154700086 | |
| 0.405 | 0.012 | 0.405 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.208 0.067 CID_154700086 | ||
| 0.401 | 0.012 | 0.401 | Src kinase inhibitor | 0.132 0.097 CID_154700086 | ||
| 0.386 | 0.003 | 0.386 | EphB4 antagonist | 0.07 0.03 CID_154700086 | ||
| 0.382 | 0.011 | 0.382 | Vascular endothelial growth factor 3 antagonist | 0.109 0.107 CID_154700086 | ||
| 0.362 | 0.007 | 0.362 | Platelet activating factor antagonist | 0.149 0.045 CID_154700086 | ||
| 0.362 | 0.01 | 0.362 | c-Src kinase inhibitor | 0.107 0.084 CID_154700086 | ||
| 0.361 | 0.015 | 0.613 | DNA methylase inhibitor | 0.613 0.004 CID_154700086 | CID_154700086 | |
| 0.348 | 0.007 | 0.348 | Protein kinase (CK2) alpha inhibitor | |||
| 0.372 | 0.031 | 0.372 | Tyrosine kinase inhibitor | |||
| 0.344 | 0.004 | 0.344 | ErbB-3 antagonist | 0.213 0.008 CID_154700086 | ||
| 0.395 | 0.081 | 0.395 | 5 Hydroxytryptamine release inhibitor | 0.38 0.091 CID_154700086 | ||
| 0.328 | 0.015 | 0.328 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.316 | 0.005 | 0.316 | Raf kinase C inhibitor | |||
| 0.308 | 0.002 | 0.308 | Fructose-1,6-bisphosphatase inhibitor | 0.051 0.024 CID_154700086 | ||
| 0.304 | 0.004 | 0.304 | EphA2 antagonist | 0.254 0.006 CID_154700086 | ||
| 0.325 | 0.026 | 0.325 | CDC-like kinase 4 inhibitor | |||
| 0.304 | 0.011 | 0.304 | Vascular endothelial growth factor 1 antagonist | 0.083 0.081 CID_154700086 | ||
| 0.293 | 0.017 | 0.293 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.141 0.082 CID_154700086 | ||
| 0.274 | 0.003 | 0.274 | MAP kinase kinase 1 inhibitor | |||
| 0.301 | 0.038 | 0.301 | Clk dual-specificity kinase inhibitor | |||
| 0.256 | 0.005 | 0.256 | MAP kinase kinase 5 inhibitor | 0.192 0.043 CID_154700086 | ||
| 0.251 | 0.004 | 0.251 | Fibroblast growth factor 2 antagonist | |||
| 0.261 | 0.022 | 0.261 | Lck kinase inhibitor | |||
| 0.247 | 0.011 | 0.247 | Protein kinase (CK2) inhibitor | |||
| 0.279 | 0.047 | 0.279 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.267 | 0.04 | 0.36 | DNA methyltransferase I inhibitor | 0.36 0.013 CID_154700086 | CID_154700086 | |
| 0.233 | 0.011 | 0.436 | Cyclooxygenase 3 inhibitor | 0.436 0.004 CID_154700086 | CID_154700086 | |
| 0.357 | 0.135 | 0.554 | Apoptosis agonist | 0.554 0.059 CID_154700086 | CID_154700086 | |
| 0.245 | 0.04 | 0.245 | LIM domain kinase 1 inhibitor | |||
| 0.208 | 0.017 | 0.208 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.204 | 0.016 | 0.204 | Platelet activating factor alpha antagonist | |||
| 0.235 | 0.051 | 0.235 | CDC-like kinase 2 inhibitor | |||
| 0.197 | 0.014 | 0.197 | Breast cancer-resistant protein inhibitor | 0.101 0.054 CID_154700086 | ||
| 0.208 | 0.035 | 0.208 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.194 | 0.023 | 0.194 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.197 | 0.032 | 0.197 | Aurora-B kinase inhibitor | |||
| 0.319 | 0.16 | 0.319 | MAP kinase 1 inhibitor | |||
| 0.172 | 0.013 | 0.172 | Platelet growth factor antagonist | 0.088 0.049 CID_154700086 | ||
| 0.172 | 0.015 | 0.172 | Raf kinase inhibitor | |||
| 0.208 | 0.056 | 0.208 | Growth factor agonist | 0.187 0.077 CID_154700086 | ||
| 0.184 | 0.033 | 0.184 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.183 | 0.033 | 0.183 | Abl kinase inhibitor | |||
| 0.175 | 0.029 | 0.175 | Aurora-C kinase inhibitor | |||
| 0.226 | 0.084 | 0.226 | Dyrk kinase inhibitor | |||
| 0.153 | 0.013 | 0.153 | Raf kinase B inhibitor | |||
| 0.186 | 0.053 | 0.186 | Polo-like kinase-3 inhibitor | |||
| 0.162 | 0.03 | 0.162 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.21 | 0.078 | 0.21 | Antimitotic | 0.156 0.115 CID_154700086 | ||
| 0.212 | 0.08 | 0.212 | EphB2 antagonist | |||
| 0.132 | 0.002 | 0.132 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.146 | 0.027 | 0.176 | Multidrug resistance-associated protein 1 inhibitor | 0.176 0.016 CID_154700086 | CID_154700086 | |
| 0.161 | 0.045 | 0.161 | MAP3K9 inhibitor | |||
| 0.144 | 0.033 | 0.144 | Fibroblast growth factor 1 antagonist | |||
| 0.147 | 0.041 | 0.147 | Aurora-A kinase inhibitor | |||
| 0.198 | 0.094 | 0.198 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.2 | 0.099 | 0.2 | RNA-directed DNA polymerase inhibitor | |||
| 0.131 | 0.031 | 0.131 | CDC-like kinase 3 inhibitor | |||
| 0.12 | 0.021 | 0.12 | Purinergic P2X2 antagonist | |||
| 0.16 | 0.063 | 0.16 | CDC-like kinase 1 inhibitor | |||
| 0.183 | 0.086 | 0.183 | Death-associated protein kinase 3 inhibitor | |||
| 0.123 | 0.03 | 0.123 | TIE antagonist | |||
| 0.122 | 0.029 | 0.122 | TIE-2 antagonist | |||
| 0.112 | 0.024 | 0.112 | Keratolytic | |||
| 0.116 | 0.032 | 0.116 | Polo-like kinase-1 inhibitor | |||
| 0.147 | 0.069 | 0.147 | Activin receptor-like kinase 2 inhibitor | |||
| 0.106 | 0.029 | 0.106 | Fibroblast growth factor 3 antagonist | |||
| 0.114 | 0.038 | 0.114 | Insulin growth factor antagonist | |||
| 0.102 | 0.027 | 0.102 | Syk tyrosine kinase inhibitor | |||
| 0.082 | 0.008 | 0.082 | Phosphoglycerate kinase inhibitor | 0.034 0.025 CID_154700086 | ||
| 0.108 | 0.034 | 0.108 | Bcr-Abl kinase inhibitor | |||
| 0.17 | 0.101 | 0.17 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.105 | 0.038 | 0.105 | Insulin like growth factor 1 antagonist | |||
| 0.094 | 0.031 | 0.094 | Transforming growth factor beta 3 antagonist | |||
| 0.097 | 0.037 | 0.097 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.085 | 0.029 | 0.085 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.131 | 0.078 | 0.131 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.076 | 0.024 | 0.076 | Heat shock protein 90 beta antagonist | |||
| 0.084 | 0.034 | 0.084 | Glutamate (mGluR group I) antagonist | |||
| 0.209 | 0.16 | 0.57 | Transcription factor NF kappa B inhibitor | 0.57 0.035 CID_154700086 | CID_154700086 | |
| 0.075 | 0.027 | 0.075 | Phosphodiesterase 1B inhibitor | |||
| 0.056 | 0.009 | 0.056 | Purinergic P2X3 antagonist | |||
| 0.059 | 0.014 | 0.059 | Thymidine kinase inhibitor | 0.037 0.036 CID_154700086 | ||
| 0.118 | 0.075 | 0.118 | TRKB antagonist | |||
| 0.102 | 0.061 | 0.102 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.196 | 0.156 | 0.242 | Hypoxia-inducible factor 1 alpha inhibitor | 0.242 0.108 CID_154700086 | CID_154700086 | |
| 0.093 | 0.053 | 0.093 | Phosphodiesterase I inhibitor | |||
| 0.045 | 0.008 | 0.045 | Estrogen-related receptor beta antagonist | |||
| 0.075 | 0.04 | 0.075 | Vanilloid 1 antagonist | |||
| 0.08 | 0.045 | 0.08 | MAP kinase kinase 7 inhibitor | |||
| 0.087 | 0.053 | 0.087 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.079 | 0.048 | 0.079 | MAP kinase 7 inhibitor | |||
| 0.07 | 0.041 | 0.07 | Potassium channel (ATP-sensitive) blocker | |||
| 0.063 | 0.034 | 0.063 | Fibroblast growth factor 4 antagonist | |||
| 0.078 | 0.051 | 0.078 | Glutamate (mGluR) antagonist | |||
| 0.106 | 0.081 | 0.231 | Alkylator | 0.231 0.019 CID_154700086 | CID_154700086 | |
| 0.144 | 0.12 | 0.144 | Catenin beta inhibitor | |||
| 0.157 | 0.133 | 0.157 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.032 | 0.009 | 0.032 | Adenosine kinase inhibitor | |||
| 0.053 | 0.031 | 0.053 | Antiviral (Hepatitis D) | |||
| 0.086 | 0.065 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.05 | 0.029 | 0.05 | Glutamate (mGluR5) antagonist | |||
| 0.032 | 0.012 | 0.032 | DNA polymerase III inhibitor | |||
| 0.135 | 0.115 | 0.135 | TRKC antagonist | |||
| 0.051 | 0.031 | 0.051 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.072 | 0.054 | 0.072 | Protein kinase B gamma inhibitor | |||
| 0.058 | 0.042 | 0.058 | CDK9/cyclin T1 inhibitor | |||
| 0.074 | 0.059 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.108 | 0.093 | 0.108 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.077 | 0.063 | 0.077 | ALK inhibitor | |||
| 0.028 | 0.015 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.102 | 0.092 | 0.102 | Interleukin 8 antagonist | |||
| 0.068 | 0.059 | 0.068 | Vanilloid antagonist | |||
| 0.066 | 0.058 | 0.066 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.121 | 0.113 | 0.145 | CC chemokine 6 receptor antagonist | 0.145 0.029 CID_154700086 | CID_154700086 | |
| 0.081 | 0.073 | 0.081 | Hepatocyte growth factor antagonist | |||
| 0.024 | 0.017 | 0.024 | Adenosine A1 receptor agonist | 0.023 0.017 CID_154700086 | ||
| 0.203 | 0.198 | 0.203 | Toll-Like receptor agonist | |||
| 0.052 | 0.047 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.013 | 0.01 | 0.013 | DNA polymerase III polC-type inhibitor | |||
| 0.1 | 0.121 | 0.117 | Protein kinase stimulant | 0.117 0.096 CID_154700086 | CID_154700086 | |
| 0.02 | 0.06 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.008 CID_154700086 | CID_154700086 | |
| 0.152 | 0.2 | 0.244 | DNA synthesis inhibitor | 0.244 0.07 CID_154700086 | CID_154700086 | |
| 0.068 | 0.133 | 0.153 | Xanthine oxidase inhibitor | 0.153 0.033 CID_154700086 | CID_154700086 | |
| 0.168 | 0.232 | 0.411 | Immunosuppressant | 0.411 0.058 CID_154700086 | CID_154700086 | |
| 0.223 | 0.288 | 0.306 | Caspase 9 stimulant | 0.306 0.187 CID_154700086 | CID_154700086 | |
| 0.167 | 0.251 | 0.305 | Histamine release inhibitor | 0.305 0.121 CID_154700086 | CID_154700086 | |
| 0.066 | 0.155 | 0.127 | Beta amyloid protein antagonist | 0.127 0.061 CID_154700086 | CID_154700086 | |
| 0.085 | 0.183 | 0.135 | Amyloid beta aggregation inhibitor | 0.135 0.12 CID_154700086 | CID_154700086 | |
| 0.057 | 0.156 | 0.122 | NADH dehydrogenase inhibitor | 0.122 0.028 CID_154700086 | CID_154700086 | |
| 0.058 | 0.164 | 0.082 | Thioredoxin inhibitor | 0.082 0.078 CID_154700086 | CID_154700086 | |
| 0.029 | 0.137 | 0.059 | Factor IXa inhibitor | 0.059 0.027 CID_154700086 | CID_154700086 | |
| 0.056 | 0.178 | 0.11 | Transcription factor NF kappa B stimulant | 0.11 0.031 CID_154700086 | CID_154700086 | |
| 0.099 | 0.248 | 0.171 | ATPase inhibitor | 0.171 0.069 CID_154700086 | CID_154700086 | |
| 0.03 | 0.188 | 0.087 | Topoisomerase II alpha inhibitor | 0.087 0.048 CID_154700086 | CID_154700086 | |
| 0.05 | 0.212 | 0.139 | DNA polymerase I inhibitor | 0.139 0.055 CID_154700086 | CID_154700086 | |
| 0.007 | 0.18 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.018 CID_154700086 | CID_154700086 | |
| 0.009 | 0.183 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 CID_154700086 | CID_154700086 | |
| 0.123 | 0.297 | 0.363 | Vasodilator, coronary | 0.363 0.049 CID_154700086 | CID_154700086 | |
| 0.061 | 0.242 | 0.128 | Interleukin 4 antagonist | 0.128 0.074 CID_154700086 | CID_154700086 | |
| 0.075 | 0.259 | 0.252 | Nitric oxide antagonist | 0.252 0.051 CID_154700086 | CID_154700086 | |
| 0.18 | 0.364 | 0.601 | Antiinflammatory | 0.601 0.053 CID_154700086 | CID_154700086 | |
| 0.076 | 0.264 | 0.155 | Insulin secretagoues | 0.155 0.07 CID_154700086 | CID_154700086 | |
| 0.035 | 0.251 | 0.08 | ATPase (Vacuolar H+) inhibitor | 0.08 0.078 CID_154700086 | CID_154700086 | |
| 0.074 | 0.296 | 0.155 | Non-steroidal antiinflammatory agent | 0.155 0.109 CID_154700086 | CID_154700086 | |
| 0.088 | 0.321 | 0.366 | Hypoglycemic | 0.366 0.034 CID_154700086 | CID_154700086 | |
| 0.037 | 0.274 | 0.094 | Cell adhesion molecule inhibitor | 0.094 0.039 CID_154700086 | CID_154700086 | |
| 0.046 | 0.288 | 0.149 | Toll-Like receptor 4 antagonist | 0.149 0.021 CID_154700086 | CID_154700086 | |
| 0.048 | 0.305 | 0.161 | Cell adhesion inhibitor | 0.161 0.04 CID_154700086 | CID_154700086 | |
| 0.046 | 0.314 | 0.454 | Angiogenesis stimulant | 0.454 0.015 CID_154700086 | CID_154700086 | |
| 0.02 | 0.292 | 0.051 | Glucose-6-phosphate translocase inhibitor | 0.051 0.037 CID_154700086 | CID_154700086 | |
| 0.059 | 0.337 | 0.163 | Antiamyloidogenic | 0.163 0.13 CID_154700086 | CID_154700086 | |
| 0.022 | 0.314 | 0.118 | Topoisomerase I inhibitor | 0.118 0.056 CID_154700086 | CID_154700086 | |
| 0.101 | 0.427 | 0.198 | Caspase 3 stimulant | 0.198 0.173 CID_154700086 | CID_154700086 | |
| 0.08 | 0.433 | 0.331 | Immunomodulator | 0.331 0.067 CID_154700086 | CID_154700086 | |
| 0.07 | 0.436 | 0.409 | Antithrombotic | 0.409 0.047 CID_154700086 | CID_154700086 | |
| 0.089 | 0.467 | 0.307 | Apoptosis antagonist | 0.307 0.081 CID_154700086 | CID_154700086 | |
| 0.036 | 0.416 | 0.334 | Immunostimulant | 0.334 0.069 CID_154700086 | CID_154700086 | |
| 0.038 | 0.439 | 0.32 | Free radical scavenger | 0.32 0.047 CID_154700086 | CID_154700086 | |
| 0.044 | 0.449 | 0.327 | Antioxidant | 0.327 0.053 CID_154700086 | CID_154700086 | |
| 0.041 | 0.456 | 0.198 | Vasodilator | 0.198 0.106 CID_154700086 | CID_154700086 | |
| 0.05 | 0.467 | 0.13 | Interferon gamma antagonist | 0.13 0.112 CID_154700086 | CID_154700086 | |
| 0.042 | 0.461 | 0.269 | Tumour necrosis factor alpha release inhibitor | 0.269 0.066 CID_154700086 | CID_154700086 | |
| 0.008 | 0.428 | 0.246 | Selectin antagonist | 0.246 0.008 CID_154700086 | CID_154700086 | |
| 0.089 | 0.514 | 0.27 | Peptidyltransferase inhibitor | 0.27 0.038 CID_154700086 | CID_154700086 | |
| 0.022 | 0.47 | 0.136 | Thrombolytic | 0.136 0.093 CID_154700086 | CID_154700086 | |
| 0.078 | 0.539 | 0.487 | Cyclophilin D inhibitor | 0.487 0.054 CID_154700086 | CID_154700086 | |
| 0.042 | 0.527 | 0.272 | Hepatoprotectant | 0.272 0.038 CID_154700086 | CID_154700086 | |
| 0.01 | 0.511 | 0.058 | Protein 50S ribosomal subunit inhibitor | 0.058 0.033 CID_154700086 | CID_154700086 | |
| 0.021 | 0.524 | 0.121 | Anticoagulant | 0.121 0.111 CID_154700086 | CID_154700086 | |
| 0.045 | 0.562 | 0.188 | Cholesterol antagonist | 0.188 0.176 CID_154700086 | CID_154700086 | |
| 0.012 | 0.539 | 0.052 | Heparanase inhibitor | 0.052 0.039 CID_154700086 | CID_154700086 | |
| 0.011 | 0.56 | 0.045 | Antibiotic Aminoglycoside-like | 0.045 0.016 CID_154700086 | CID_154700086 | |
| 0.017 | 0.763 | 0.154 | Platelet adhesion inhibitor | 0.154 0.101 CID_154700086 | CID_154700086 | |
| 0.048 | 0.842 | 0.359 | Interleukin 2 agonist | 0.359 0.042 CID_154700086 | CID_154700086 | |
| 0.005 | 0.879 | 0.255 | Antibacterial | 0.255 0.172 CID_154700086 | CID_154700086 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |